Oxford BioMedica wins second $100 mln gene therapy contract – Reuters
|
Oxford BioMedica wins second $100 mln gene therapy contract
Reuters Oxford Bio, which listed in London in 1996 after being spun out of research at the University of Oxford, has faced a slow road to profit, mirroring the waxing and waning of the gene therapy field over two decades. Now, however, gene and cell therapy is … |
